Global Sodium Channel Blockers Market is Segmented By Product (Antiarrhythmic Agents, Local Anesthetics, Anticonvulsants, Analgesics, and Others), By Therapeutic Area (Cardiology, Neurology, Anesthesiology, Pain Management, and Others), By Route of Administration (Oral, Parenteral, and Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa). The report offers the value (in USD Billion) for the above-mentioned segments.
The major players operating in the global sodium channel blockers market include, Biogen, Merck & Co., Parion Sciences, AlphaNavi Pharma, Vertex Pharmaceuticals, SK biopharmaceuticals, UCB Biopharma, Mylan Pharmaceuticals, Daewoong Pharmaceutical Co. Ltd., and Bio-Techne.
Global Sodium Channel Blockers Market